Egetis Therapeutics AB (OSTO:PLED BTA) Other Income (Expense) : kr9.10 Mil (TTM As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Egetis Therapeutics AB Other Income (Expense)?

Egetis Therapeutics AB's other income expense for the Egetis Therapeutics AB's pretax income for the three months ended in Mar. 2025 was kr10.30 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2025 was kr9.10 Mil.

Egetis Therapeutics AB Other Income (Expense) Historical Data

The historical data trend for Egetis Therapeutics AB's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Egetis Therapeutics AB Other Income (Expense) Chart

Egetis Therapeutics AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Other Income (Expense)

Get a 7-Day Free Trial

-1.13

0.70

2.50

-16.20

-10.70

Egetis Therapeutics AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Income (Expense)	Get a 7-Day Free Trial															-3.40	8.20	-1.70	-7.70	10.30

Egetis Therapeutics AB Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr9.10 Mil.

Egetis Therapeutics AB (OSTO:PLED BTA) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.

Egetis Therapeutics AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Egetis Therapeutics AB (OSTO:PLED BTA) » Definitions » Other Income (Expense)

Comparable Companies

Traded in Other Exchanges

EGTX:Sweden 0ABW:UK P0F:Germany

Address

Grev Turegatan 11 C, Stockholm, SWE, 114 46

Website

https://www.egetis.com

Egetis Therapeutics AB is an integrated pharmaceutical drug development company, focusing on projects in late-stage development for the treatment of serious rare/niche diseases with unmet medical needs in the orphan drug segment.

Egetis Therapeutics AB Headlines

No Headlines